Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20150825001Phase 3Not yet recruiting
Phase 3, open-label, single-arm trial in limbal stem cell deficiency (LSCD), sponsored by Government Research Budget. Primary endpoint: Success rate of transplantation. Planned start Sep 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20150825001.